Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of K-ras and p53 expression in pancreatic adenocarcinoma using the cancer genome atlas.

PloS one - 1 Jan 2017

Lu Liming, Zeng Jingchun

Abstract excerpt

Genetic alterations in K-ras and p53 are thought to be critical in pancreatic cancer development and progression. However, K-ras and p53 expression in pancreatic adenocarcinoma have not been systematically examined in The Cancer Genome Atlas (TCGA) Data Portal. Information regarding K-ras and p53 alterations, mRNA expression data, and protein/protein phosphorylation abundance was retrieved from The Cancer Genome...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Gene Regulatory Networks
Share to Genes, p53

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, ras

Share to Kaplan-Meier Estimate

Share to Pancreas

Share to Pancreatic Neoplasms

Share to Proto-Oncogene Proteins p21(ras)

Source

Open in PubMed Open full text

Identifiers

PMID: 28742845
DOI: 10.1371/journal.pone.0181532
PMCID: PMC5526503

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of K-ras and p53 expression in pancreatic adenocarcinoma using the cancer genome atlas.PMID 28742845Read ↗

The cornerstone K-RAS mutation in pancreatic adenocarcinoma: From cell signaling network, target genes, biological processes to therapeutic targeting.Semantic proximity Read ↗

Oncogenesis and the clinical significance of K-ras in pancreatic adenocarcinoma.Semantic proximity Read ↗

Prevalence and clinical significance of combined K-ras mutation and p53 aberration in pancreatic adenocarcinoma.Semantic proximity Read ↗

Beyond the Genomic Mutation: Rethinking the Molecular Biomarkers of K-RAS Dependency in Pancreatic Cancers.Semantic proximity Read ↗

Prognostic significance of K-ras mutations in pancreatic cancer: a meta-analysis.Semantic proximity Read ↗

High p53 Protein Level Is a Negative Prognostic Marker for Pancreatic Adenocarcinoma.Semantic proximity Read ↗

K-Ras mutation detection in liquid biopsy and tumor tissue as prognostic biomarker in patients with pancreatic cancer: a systematic review with meta-analysis.Semantic proximity Read ↗

Patterns of genetic alterations in pancreatic cancer: a pooled analysis.Semantic proximity Read ↗

NUAK2 and RCan2 participate in the p53 mutant pro-tumorigenic networkSemantic proximity Read ↗

Multifaceted role for p53 in pancreatic cancer suppressionSemantic proximity Read ↗

In vitro Modeling of Human Pancreatic Duct Epithelial Cell Transformation Defines Gene Expression Changes Induced by K- ras Oncogenic Activation in Pancreatic CarcinogenesisSemantic proximity Read ↗

MicroRNA regulation of K-Ras in pancreatic cancer and opportunities for therapeutic intervention.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.